Novartis Ag (NVS) FCF Payout Ratio (2009 - 2026)

Novartis Ag has disclosed FCF Payout Ratio across 18 years of filings, most recently posting 0.46 for Q2 2026.

• In Q2 2026, FCF Payout Ratio fell 30.28% year-over-year to 0.46; the TTM figure through Jun 2026 stood at 0.6 (up 1.83% YoY), while the FY2025 annual figure was 0.38, up 5.91% from the prior year.
• FCF Payout Ratio came in at 0.46 for Q2 2026 at Novartis Ag, up from 1.54 in the prior quarter.
• In the past five years, FCF Payout Ratio ranged from a high of 0.36 in Q2 2025 to a low of 3.94 in Q1 2022.
• Average FCF Payout Ratio over 5 years is 1.43, with a median of 1.18 recorded in 2024.
• Year-over-year, FCF Payout Ratio surged 41.05% in 2023 and slumped 30.28% in 2026.
• Over 5 years, FCF Payout Ratio stood at 3.94 in 2022, then surged by 41.05% to 2.32 in 2023, then soared by 57.34% to 0.99 in 2024, then grew by 27.7% to 0.72 in 2025, then soared by 35.36% to 0.46 in 2026.
• Per Business Quant data, the three most recent FCF Payout Ratio figures were 0.46 in Q2 2026, 1.54 in Q1 2026, and 0.72 in Q4 2025.